Merck Arcoxia Acute Gout Trials Use Appropriate Comparator, Cmte. Says

Merck's comparison of Arcoxia to indomethacin in trials of acute gout is appropriate even though there is little formal data on indomethacin's efficacy, FDA's Arthritis Advisory Committee said

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet